To investigate the capacity of POLQ-deficient cells to escape a telomere-driven crisis, we employed retroviral transduction to suppress telomerase function in two independent human cancer cell lines, HCT116 and HAP1, that had undergone CRISPR/Cas9-mediated mutation of the POLQ gene (Supplementary Figure S1Ai). The gene discussed is POLQ; the disease is cancer.